ACS and Heart Failure
- Establish the diagnosis and therapy of acute coronary syndrome.
- Formulate the indications for fibrinolysis, glycoprotein llb/lIla agents, and angioplasty in acute coronary syndrome.
- Analyze the difference between systolic and diastolic cardiac dysfunction.
- Differentiate the therapies that increase the chance for survival in patients with heart failure and those that only improve symptoms.
- Review the role of neurohormonal activation in systolic heart failure.
View technical requirements (opens in a new window).
View CME credit information (opens in a new window).
View AAFP staff list (opens in a new window).
View disclosures (opens in a new window).
View disclaimers (opens in a new window).
© 2012 American Academy of Family Physicians. Materials/Contents are not to be reproduced, published or distributed, in whole or in part, in any form or medium, without the express written permission of the American Academy of Family Physicians.
Warning: The unauthorized reproduction or distribution of this copyrighted work is illegal. Criminal copyright infringement, including infringement without monetary gain, is investigated by the FBI and is punishable by up to five years in federal prison and a fine of $250,000.
Jonathon Firnhaber, MD, FAAFP, Associate Professor, Residency Director, Department of Family Medicine, Brody School of Medicine at East Carolina University, Greenville, North Carolina
- 0.75 AAFP prescribed